Ipamorelin is a synthetic pentapeptide developed for laboratory research into growth hormone secretagogue pathways. It is structurally classified as a ghrelin receptor (GHS-R) agonist and is studied for its selective interaction with growth hormone–releasing mechanisms in experimental models.
In research settings, ipamorelin is of interest due to its high receptor specificity and limited interaction with other endocrine signaling pathways compared to earlier growth hormone secretagogues. Its short peptide length and defined structure make it suitable for controlled in vitro and preclinical investigation.
Ipamorelin is supplied in lyophilized (freeze-dried) form to preserve molecular stability during storage and transport.
For research purposes only. Not for human consumption.
| Specification |
Detail |
| Compound Name |
Ipamorelin |
| Classification |
Synthetic growth hormone secretagogue peptide |
| Peptide Type |
Linear pentapeptide |
| Molecular Formula |
C₃₈H₄₉N₉O₅ |
| Molecular Weight |
711.85 g/mol |
| Amino Acid Length |
5 amino acids |
| Purity |
≥99% (HPLC verified) |
| Form |
Lyophilized powder |
| Quantity |
10 mg per vial |
| Solubility |
Soluble in aqueous solutions (research handling) |
| Testing |
HPLC / MS |
| COA |
Available per batch |
| Storage |
Store refrigerated (2–8 °C) or frozen for long-term stability |
| CAS Number |
170851-70-4 |